NCT02806830

Ocular Discomfort Assessment After Intravitreal Injections

Evaluation de la gêne Oculaire après Injections intravitréennes

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 45 (actual)
• Sponsor: Centre Hospitalier Intercommunal Creteil · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

In this study, ocular discomfort following intravitreal injection in naïve patients will be studied, as well as the efficacy of wetting agent (Optive eyewash) to prevent ocular discomfort.

Detailed description

In naive patients, the two first intravitreal injections will be studied. Within the first injection, no wetting agent will be delivered. Within 72hours after this first intravitreal injections, patients will be contacted by phone by a nurse to complete questionnaires on quality of life and on ocular pain and eye discomfort. After the second injection, a treatment with wetting agent will be prescribed. With 72hours after the second injection, quality of life, ocular discomfort as well as acceptability and tolerance of the eye drops will also be assessed by a phone questionnaire.

Conditions

• Macular Degeneration
• Diabetic Retinopathy
• Retinal Artery Occlusion
• Myopia, Degenerative

Interventions

Type	Name	Description
DRUG	Optive	Optive eye drops will be prescribed to each included patients after their second intravitreal injection; patients will received 1 drop in the affected eye 2 times a day during 3 days

Timeline

• Start date: 2016-04-01
• Primary completion: 2017-01-01
• Completion: 2017-07-01
• First posted: 2016-06-21
• Last updated: 2017-07-28

Locations

1 site across 1 country: France